Form 4 Tracker
Matthew Pauls

Director · 5 filings · Latest: Jul 2, 2026

PALVELLA THERAPEUTICS, INC.
Pelthos Therapeutics Inc.
SOLENO THERAPEUTICS INC
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
PTHS
Matthew PaulsDirectorJul 2, 2026
Sale
$26.16786$20.6K14,364
PTHS
Matthew PaulsDirectorApr 2, 2026
Sale
$20.92786$16.4K15,150
SLNO
Matthew PaulsMar 28, 2025
Proposed Sale
$67.395,937$400.1K
SVRA
Pauls MatthewDec 16, 2024
Proposed Sale
$3.3154,702$180.8K